Accuracy, efficacy and safety of dengue CYD-TDV pre-vaccination screening with 5 existing IgG serotests: Retrospective analysis of phase III trials

Accuracy, efficacy and safety of dengue CYD-TDV pre-vaccination screening with 5 existing IgG serotests: Retrospective analysis of phase III trials

Bibliographic Details
Main Authors:	C. Diazgranados, M. Bonaparte, Y. Lustig, R. Forrat, G. Dayan, H. Wang, M. Zhu, S. Hodge, E. Schwartz, Y. Ataman-Onal, S. Savarino
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220319706

Similar Items

Safety of dengue vaccine (CYD-TDV) in Asia: a systematic review
by: W. R. Wan Ismail, et al.
Published: (2021-06-01)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-04-01)

Safety of dengue vaccine (CYD-TDV) in Asia: A systematic review
by: Wan Rosmawati Wan Ismail, et al.
Published: (2020)

Efficacy of Live Attenuated Dengue Vaccines: CYD-TDV, TDV (TAK-003), and TV003/TV005
by: Yoseph Jeffry Hertanto, et al.
Published: (2021-12-01)

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
by: Lindsay N Carpp, et al.
Published: (2020-01-01)

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
by: Dorigatti, I, et al.
Published: (2018)

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning
by: I. Dorigatti, et al.
Published: (2018-09-01)

Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening
by: Vasco Liberal, et al.
Published: (2022-06-01)

Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data
by: Daniel J Laydon, et al.
Published: (2021-07-01)

Low antibody titers five years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
by: Velumani, Sumathy, et al.
Published: (2016)

Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program
by: Mauricio Hernández-Ávila, et al.
Published: (2016-01-01)

Analysis of the evidence about the efficacy and safety of the CYD-TDV dengue vaccine and its potential licensing and implementation within the Mexican Universal Vaccination Program
by: Mauricio Hernández-Ávila, et al.
Published: (2016-02-01)

Clinical Efficacy, Safety, and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (CYD-TDV) in Children: A Systematic Review with Meta-analysis
by: Moffat Malisheni, et al.
Published: (2017-08-01)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019-10-01)

Long-term safety follow-up of children from a randomized—controlled phase II b proof—of—concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD—TDV) in Thailand
by: Kriengsak Limkittikul, et al.
Published: (2019-01-01)

Serotesting of Human Brucellosis on Wider Area of Bosnia and Herzegovina
by: Sadeta Hamzić, et al.
Published: (2005-08-01)

Genetic epidemiology of dengue virus in phase III trials of the CYD tetravalent vaccine and implications for efficacy
by: Rabaa, MA, et al.
Published: (2017)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
by: Maia A Rabaa, et al.
Published: (2017-09-01)

Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
by: Olayinka M. Olajiga, et al.
Published: (2022-10-01)

IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections.
by: Jenny C Cardenas, et al.
Published: (2019-01-01)

The value of IgG to IgM ratio in predicting secondary dengue infection
by: I Putu Gede Karyana, et al.
Published: (2016-10-01)

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
by: Jih-Jin Tsai, et al.
Published: (2023-05-01)

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
by: Judith Kirstein, et al.
Published: (2018-09-01)

Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
by: Jih-Jin Tsai, et al.
Published: (2023-06-01)

A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests
by: Miriam Klausberger, et al.
Published: (2021-05-01)

Rasio IgM/IgG Fase Akut Untuk Menentukan Infeksi Dengue Sekunder
by: Bagus Ngurah Putu Arhana
Published: (2016-12-01)

Significance of IgG optical density ratios (index value) in single reactive anti-Dengue virus IgG capture ELISA
by: Shiv Sekhar Chatterjee, et al.
Published: (2017-03-01)

Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis
by: Noordin, R., et al.
Published: (2005)

Co-existing ligneous conjunctivitis and IgG4-related disease
by: Wei-Yu Chiang, et al.
Published: (2016-01-01)

Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection
by: Balakrishnan, T., et al.
Published: (2011)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
by: Lucas A. Schulte, et al.
Published: (2020-08-01)

Differentiating Secondary Dengue Using IgG/IgM Antibody Ratio: A Cross-sectional Study
by: Therese Mary Dhason, et al.
Published: (2023-07-01)

Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood
by: Tran Binh Q, et al.
Published: (2006-01-01)

Field evaluation and impact on clinical management of a rapid diagnostic kit that detects dengue NS1, IgM and IgG.
by: Anne-Claire Andries, et al.
Published: (2012-01-01)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
by: Andrew Teo, et al.
Published: (2023-03-01)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
by: Andrew Teo, et al.
Published: (2023-03-01)

Understanding antibody-dependent enhancement in dengue: are afucosylated IgG1s a concern?
by: Teo, Andrew, et al.
Published: (2023)

Purificación de IgG1, IgG2 e IgG3 mediante cromatografía de afinidad a partir de intacglobín Purification of IgG1, IgG2 and IgG3 by affinity chromatography starting from Intacglobin
by: Ada A Arce Hernández, et al.
Published: (2001-08-01)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Rodrigo V. Motta, et al.
Published: (2024-02-01)